ISHLT 2026 Heart Symposium - Dr. Palak Shah

QAPI Overview- Dr. Rosenheck

The PEDAL Study: Prospera dd-cfDNA use in post-rejection monitoring

Redefining heart transplant care: How donor-derived cell-free DNA is transforming rejection surveillance

This webinar highlights the DEFINE-HT study initial results and the two-threshold algorithm: fraction + DQS.

Prospera in Practice: Nursing Strategies for "High-risk" Results

Prospera in Practice: Nursing Strategies for High-Risk Cases

Beyond Biopsy: Cell-free DNA is not just to rule out rejection

ISHLT 2025 - Enhancing overall dd-cfDNA testing accuracy in heart transplantation using fraction and donor quality score(DQS)

Clinical Conundrum: When cDNA & Biopsy Don't Agree

What Nurses Need to Know: Implementing a Prospera™ Surveillance Protocol

Cell-free DNA testing: An alternative option to surveillance biopsy in children

An overview of cell-free DNA technology and its application in pediatric heart transplantation

A Roundtable Conversation on Post-transplant Care

How to Engage Your Kidney Transplant Recipients

Being Proactive with Prospera on Their Transplant Care